Yang, Donglin
Hou, Xiaoqiang
Qian, Kun
Li, Yuhang
Hu, Liangding
Li, Liang
Han, Mingzhe
Yao, Chen
Liu, Daihong http://orcid.org/0000-0003-3334-9113
Funding for this research was provided by:
National Natural Science Foundation of China (82070178)
Article History
Received: 31 July 2022
Accepted: 10 April 2023
First Online: 3 May 2023
Declarations
:
: This study follows the principles of the Helsinki Declaration 2013, Good Clinical Practice in clinical trials, and Chinese regulations. The study protocol version 6.0 of May 2021 was approved by the independent ethics committee of the leading center General Hospital of the Chinese People’s Liberation Army (NO. C2020-016–05) on 25 August 2021. Informed written consent will be obtained from each participant or his or her legal representative (for subjects < 18 years of age) prior to registration into the trial.
: After the trial is completed, a summary report will be submitted for publication with the consent of the sponsor, and investigators who have made significant contributions to the study will be included in the list of authors.
: The authors declare no competing interests.